Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 94 Pages
Report ld: 5353174
Request Sample
Customized Report
STD Rapid Antibody Test Market Size(US$)

CAGR 2025-2031
5.1%
Market Size,2031
USD 100
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global STD Rapid Antibody Test market size was US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on STD Rapid Antibody Test market competitiveness, regional economic performance, and supply chain configurations.
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
With the increasing openness of society, sexual health has gained significant attention. The STD Rapid Antibody Test has become an essential product in the market due to its rapid and convenient nature. This testing method can quickly detect antibodies related to various sexually transmitted diseases in a short period, aiding individuals in understanding their sexual health status and taking necessary measures for early treatment and prevention. Market trends indicate that modern individuals are placing a higher emphasis on health, particularly sexual health. As a result, there is a growing demand for STD Rapid Antibody Tests in medical facilities, sexual health institutions, and even through online retail channels. However, consumers are also becoming more concerned about the accuracy and reliability of such products. Manufacturers must rigorously ensure product quality to guarantee result accuracy and win the trust of consumers.
The global STD Rapid Antibody Test market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of STD Rapid Antibody Test market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Gonorrhoea Testing in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Homecare in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the STD Rapid Antibody Test value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 STD Rapid Antibody Test Product Scope
1.2 STD Rapid Antibody Test by Type
1.2.1 Global STD Rapid Antibody Test Sales by Type (2020 & 2024 & 2031)
1.2.2 Chlamydia Testing
1.2.3 Gonorrhoea Testing
1.2.4 Hepatitis C Testing
1.2.5 HIV Testing
1.2.6 Syphilis Testing
1.2.7 Others
1.3 STD Rapid Antibody Test by Application
1.3.1 Global STD Rapid Antibody Test Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Diagnostic Centres
1.4 Global STD Rapid Antibody Test Market Estimates and Forecasts (2020-2031)
1.4.1 Global STD Rapid Antibody Test Market Size in Value Growth Rate (2020-2031)
1.4.2 Global STD Rapid Antibody Test Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global STD Rapid Antibody Test Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global STD Rapid Antibody Test Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global STD Rapid Antibody Test Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global STD Rapid Antibody Test Sales Market Share by Region (2020-2025)
2.2.2 Global STD Rapid Antibody Test Revenue Market Share by Region (2020-2025)
2.3 Global STD Rapid Antibody Test Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global STD Rapid Antibody Test Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global STD Rapid Antibody Test Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America STD Rapid Antibody Test Market Size and Prospective (2020-2031)
2.4.2 Europe STD Rapid Antibody Test Market Size and Prospective (2020-2031)
2.4.3 China STD Rapid Antibody Test Market Size and Prospective (2020-2031)
2.4.4 Japan STD Rapid Antibody Test Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global STD Rapid Antibody Test Historic Market Review by Type (2020-2025)
3.1.1 Global STD Rapid Antibody Test Sales by Type (2020-2025)
3.1.2 Global STD Rapid Antibody Test Revenue by Type (2020-2025)
3.1.3 Global STD Rapid Antibody Test Price by Type (2020-2025)
3.2 Global STD Rapid Antibody Test Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global STD Rapid Antibody Test Sales Forecast by Type (2026-2031)
3.2.2 Global STD Rapid Antibody Test Revenue Forecast by Type (2026-2031)
3.2.3 Global STD Rapid Antibody Test Price Forecast by Type (2026-2031)
3.3 Different Types STD Rapid Antibody Test Representative Players
4 Global Market Size by Application
4.1 Global STD Rapid Antibody Test Historic Market Review by Application (2020-2025)
4.1.1 Global STD Rapid Antibody Test Sales by Application (2020-2025)
4.1.2 Global STD Rapid Antibody Test Revenue by Application (2020-2025)
4.1.3 Global STD Rapid Antibody Test Price by Application (2020-2025)
4.2 Global STD Rapid Antibody Test Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global STD Rapid Antibody Test Sales Forecast by Application (2026-2031)
4.2.2 Global STD Rapid Antibody Test Revenue Forecast by Application (2026-2031)
4.2.3 Global STD Rapid Antibody Test Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in STD Rapid Antibody Test Application
5 Competition Landscape by Players
5.1 Global STD Rapid Antibody Test Sales by Players (2020-2025)
5.2 Global Top STD Rapid Antibody Test Players by Revenue (2020-2025)
5.3 Global STD Rapid Antibody Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Rapid Antibody Test as of 2024)
5.4 Global STD Rapid Antibody Test Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of STD Rapid Antibody Test, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of STD Rapid Antibody Test, Product Type & Application
5.7 Global Key Manufacturers of STD Rapid Antibody Test, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America STD Rapid Antibody Test Sales by Company
6.1.1.1 North America STD Rapid Antibody Test Sales by Company (2020-2025)
6.1.1.2 North America STD Rapid Antibody Test Revenue by Company (2020-2025)
6.1.2 North America STD Rapid Antibody Test Sales Breakdown by Type (2020-2025)
6.1.3 North America STD Rapid Antibody Test Sales Breakdown by Application (2020-2025)
6.1.4 North America STD Rapid Antibody Test Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe STD Rapid Antibody Test Sales by Company
6.2.1.1 Europe STD Rapid Antibody Test Sales by Company (2020-2025)
6.2.1.2 Europe STD Rapid Antibody Test Revenue by Company (2020-2025)
6.2.2 Europe STD Rapid Antibody Test Sales Breakdown by Type (2020-2025)
6.2.3 Europe STD Rapid Antibody Test Sales Breakdown by Application (2020-2025)
6.2.4 Europe STD Rapid Antibody Test Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China STD Rapid Antibody Test Sales by Company
6.3.1.1 China STD Rapid Antibody Test Sales by Company (2020-2025)
6.3.1.2 China STD Rapid Antibody Test Revenue by Company (2020-2025)
6.3.2 China STD Rapid Antibody Test Sales Breakdown by Type (2020-2025)
6.3.3 China STD Rapid Antibody Test Sales Breakdown by Application (2020-2025)
6.3.4 China STD Rapid Antibody Test Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan STD Rapid Antibody Test Sales by Company
6.4.1.1 Japan STD Rapid Antibody Test Sales by Company (2020-2025)
6.4.1.2 Japan STD Rapid Antibody Test Revenue by Company (2020-2025)
6.4.2 Japan STD Rapid Antibody Test Sales Breakdown by Type (2020-2025)
6.4.3 Japan STD Rapid Antibody Test Sales Breakdown by Application (2020-2025)
6.4.4 Japan STD Rapid Antibody Test Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Blue Cross Bio-Medical (Beijing)
7.1.1 Blue Cross Bio-Medical (Beijing) Company Information
7.1.2 Blue Cross Bio-Medical (Beijing) Business Overview
7.1.3 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Products Offered
7.1.5 Blue Cross Bio-Medical (Beijing) Recent Development
7.2 Guangzhou Wondfo Biotech
7.2.1 Guangzhou Wondfo Biotech Company Information
7.2.2 Guangzhou Wondfo Biotech Business Overview
7.2.3 Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Guangzhou Wondfo Biotech STD Rapid Antibody Test Products Offered
7.2.5 Guangzhou Wondfo Biotech Recent Development
7.3 OraSure
7.3.1 OraSure Company Information
7.3.2 OraSure Business Overview
7.3.3 OraSure STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.3.4 OraSure STD Rapid Antibody Test Products Offered
7.3.5 OraSure Recent Development
7.4 Roche Diagnostics
7.4.1 Roche Diagnostics Company Information
7.4.2 Roche Diagnostics Business Overview
7.4.3 Roche Diagnostics STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Roche Diagnostics STD Rapid Antibody Test Products Offered
7.4.5 Roche Diagnostics Recent Development
7.5 Abbott
7.5.1 Abbott Company Information
7.5.2 Abbott Business Overview
7.5.3 Abbott STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Abbott STD Rapid Antibody Test Products Offered
7.5.5 Abbott Recent Development
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Company Information
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Bio-Rad Laboratories STD Rapid Antibody Test Products Offered
7.6.5 Bio-Rad Laboratories Recent Development
7.7 BioMerieux
7.7.1 BioMerieux Company Information
7.7.2 BioMerieux Business Overview
7.7.3 BioMerieux STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.7.4 BioMerieux STD Rapid Antibody Test Products Offered
7.7.5 BioMerieux Recent Development
7.8 Creative Diagnostics
7.8.1 Creative Diagnostics Company Information
7.8.2 Creative Diagnostics Business Overview
7.8.3 Creative Diagnostics STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Creative Diagnostics STD Rapid Antibody Test Products Offered
7.8.5 Creative Diagnostics Recent Development
7.9 Beijing Wantai Biological Pharmacy
7.9.1 Beijing Wantai Biological Pharmacy Company Information
7.9.2 Beijing Wantai Biological Pharmacy Business Overview
7.9.3 Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Products Offered
7.9.5 Beijing Wantai Biological Pharmacy Recent Development
7.10 Chembio Diagnostic Systems
7.10.1 Chembio Diagnostic Systems Company Information
7.10.2 Chembio Diagnostic Systems Business Overview
7.10.3 Chembio Diagnostic Systems STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Chembio Diagnostic Systems STD Rapid Antibody Test Products Offered
7.10.5 Chembio Diagnostic Systems Recent Development
7.11 InTec
7.11.1 InTec Company Information
7.11.2 InTec Business Overview
7.11.3 InTec STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.11.4 InTec STD Rapid Antibody Test Products Offered
7.11.5 InTec Recent Development
7.12 Meril Life
7.12.1 Meril Life Company Information
7.12.2 Meril Life Business Overview
7.12.3 Meril Life STD Rapid Antibody Test Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Meril Life STD Rapid Antibody Test Products Offered
7.12.5 Meril Life Recent Development
8 STD Rapid Antibody Test Manufacturing Cost Analysis
8.1 STD Rapid Antibody Test Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of STD Rapid Antibody Test
8.4 STD Rapid Antibody Test Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 STD Rapid Antibody Test Distributors List
9.3 STD Rapid Antibody Test Customers
10 STD Rapid Antibody Test Market Dynamics
10.1 STD Rapid Antibody Test Industry Trends
10.2 STD Rapid Antibody Test Market Drivers
10.3 STD Rapid Antibody Test Market Challenges
10.4 STD Rapid Antibody Test Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for STD Rapid Antibody Test was estimated to be worth US$ 74.39 million in 2025 and is projected to reach US$ 105 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
The global STD Rapid Antibody Test market was valued at US$ 74.39 million in 2025 and is anticipated to reach US$ 105 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
The global STD Rapid Antibody Test market is projected to grow from US$ 71.1 million in 2024 to US$ 100 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 163
USD 4900.00
(Single User License)
The global market for STD Rapid Antibody Test was estimated to be worth US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 128
USD 3950.00
(Single User License)
The global market for STD Rapid Antibody Test was valued at US$ 71.1 million in the year 2024 and is projected to reach a revised size of US$ 100 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
The global market for STD Rapid Antibody Test was estimated to be worth US$ 74.39 million in 2025 and is projected to reach US$ 105 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 140
The global STD Rapid Antibody Test market was valued at US$ 74.39 million in 2025 and is anticipated to reach US$ 105 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 126
The global STD Rapid Antibody Test market is projected to grow from US$ 71.1 million in 2024 to US$ 100 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 163
The global market for STD Rapid Antibody Test was estimated to be worth US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 128
The global market for STD Rapid Antibody Test was valued at US$ 71.1 million in the year 2024 and is projected to reach a revised size of US$ 100 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-13
Pages: 90
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
Published: 2024-01-17
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now